Search Results - "Mazza, G L"

Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period by Lee, M. K., Basch, E., Mitchell, S. A., Minasian, L. M., Langlais, B. T., Thanarajasingam, G., Ginos, B. F., Rogak, L. J., Mendoza, T. R., Bennett, A. V., Schrag, D., Mazza, G. L., Dueck, A. C.

“…Purpose The standard recall period for the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®) is the past…”
Get full text

Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies by Hoxworth, J M, Eschbacher, J M, Gonzales, A C, Singleton, K W, Leon, G D, Smith, K A, Stokes, A M, Zhou, Y, Mazza, G L, Porter, A B, Mrugala, M M, Zimmerman, R S, Bendok, B R, Patra, D P, Krishna, C, Boxerman, J L, Baxter, L C, Swanson, K R, Quarles, C C, Schmainda, K M, Hu, L S

“…Perfusion MR imaging measures of relative CBV can distinguish recurrent tumor from posttreatment radiation effects in high-grade gliomas. Currently, relative…”
Get full text